Perrigo Company plc (PRGO)
Automate Your Wheel Strategy on PRGO
With Tiblio's Option Bot, you can configure your own wheel strategy including PRGO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PRGO
- Rev/Share 31.4844
- Book/Share 31.6921
- PB 0.856
- Debt/Equity 0.8312
- CurrentRatio 2.3589
- ROIC -0.2216
- MktCap 3729751010.0
- FreeCF/Share 1.3152
- PFCF 20.595
- PE -21.0349
- Debt/Assets 0.3717
- DivYield 0.0412
- ROE -0.0399
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | PRGO | Argus | Buy | Hold | -- | -- | Jan. 14, 2025 |
| Downgrade | PRGO | Piper Sandler | Overweight | Neutral | $34 | $27 | Jan. 6, 2025 |
| Resumed | PRGO | Jefferies | -- | Hold | $50 | $30 | Sept. 24, 2024 |
News
Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
Published: May 23, 2025 by: PRNewsWire
Sentiment: Neutral
DUBLIN , May 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference, being conducted virtually on Tuesday, June 10 at 9 AM ET. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.
Read More
Wall Street Analysts Predict a 27.28% Upside in Perrigo (PRGO): Here's What You Should Know
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Perrigo (PRGO) points to a 27.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
Is Perrigo (PRGO) Stock Undervalued Right Now?
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Perrigo (PRGO) Reliance on International Sales: What Investors Need to Know
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Evaluate Perrigo's (PRGO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Read More
Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
PRGO reports mixed first-quarter 2025 results. The top line declines, largely due to the loss of sales stemming from exited businesses and product lines.
Read More
Perrigo Company plc (PRGO) Q1 2025 Earnings Call Transcript
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral
Perrigo Company plc (NYSE:PRGO ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor - President & Chief Executive Officer Eduardo Bezerra - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Keith Devas - Jefferies Daniel Biolsi - Hedgeye Operator Good morning, ladies and gentlemen and welcome to the Perrigo Q1 2025 Financial Results Conference Call. At this time, all lines are in listen-only mode.
Read More
Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Perrigo (PRGO) Q1 Earnings Beat Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Perrigo (PRGO) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.29 per share a year ago.
Read More
Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral
Advancing 'Three-S' Plan to Stabilize, Streamline and Strengthen Perrigo, which was Detailed at February 2025 Investor Day Delivered Strong First Quarter 2025 Adjusted EPS Growth and Margin Expansion, Driven by Infant Formula and OTC Brands Widened 2025 Net Sales Target Ranges, Due Primarily to Macroeconomic Uncertainty; Reaffirmed All Other Previously Provided 2025 Financial Targets, Including Adj. EPS Range DUBLIN , May 7, 2025 /PRNewswire/ -- First Quarter 2025 Highlights: Net sales of $1.04 billion declined 3.5%, due primarily to an unfavorable impact of 3.2% from divested businesses, exited product lines and currency translation.
Read More
Perrigo to Report Q1 Earnings: Is a Beat in Store for the Stock?
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Negative
PRGO's first-quarter top line is likely to have been impacted by exited businesses and product lines, and unfavorable currency movements.
Read More
Perrigo Announces Quarterly Dividend
Published: April 30, 2025 by: PRNewsWire
Sentiment: Neutral
DUBLIN , April 30, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.290 per share, payable on June 17, 2025, to shareholders of record on May 30, 2025. About Perrigo Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.
Read More
Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
Published: April 21, 2025 by: Benzinga
Sentiment: Negative
J.P. Morgan say s Perrigo Company plc's PRGO first-quarter 2025 earnings will be dominated by commentary on the potential impact of tariffs. The analyst says, “Tariffs could potentially have a significant impact on PRGO's near-term earnings.
Read More
Perrigo Company plc (PRGO) 2025 Investor Day (Transcript)
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Perrigo Company plc (NYSE:PRGO ) Perrigo 2025 Investor Day February 28, 2025 8:00 AM ET Company Participants Brad Joseph - Vice President, Investor Relations Patrick Lockwood-Taylor - President and Chief Executive Officer Eduardo Bezerra - Executive Vice President and Chief Financial Officer Triona Schmelter - President of CSCA Roberto Khoury - President of CSCI Ron Janish - Head of Global Supply Chain Abbie Lennox - Chief Scientific Officer David Ball - Chief Marketing & Digital Officer Charles Atkinson - General Counsel Conference Call Participants Keith Devas - Jefferies Susan Anderson - Canaccord Korinne Wolfmeyer - Piper Sandler Chris Schott - …
Read More
Perrigo's Q4 Earnings Beat Estimates, Revenues Decline Y/Y
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
PRGO reports mixed Q4 2024 results. The decline in the company's top line is due to the loss of sales stemming from exited businesses and product lines.
Read More
31 Upcoming Dividend Increases, Including 3 Kings
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Positive
This week sees 31 dividend increases, including three Dividend Kings: Genuine Parts, Commerce Bancshares, and Kimberly-Clark, showcasing impressive financial stability and growth. My investment strategy prioritizes companies with consistently rising dividends and outperforming benchmarks, aiming for long-term wealth accumulation and portfolio prosperity. I use data from the "U.S. Dividend Champions" spreadsheet and NASDAQ to identify companies with at least five years of dividend growth.
Read More
Perrigo (PRGO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Perrigo (PRGO) Q4 Earnings Beat Estimates
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Perrigo (PRGO) came out with quarterly earnings of $0.93 per share, beating the Zacks Consensus Estimate of $0.92 per share. This compares to earnings of $0.86 per share a year ago.
Read More
Perrigo Reports Fourth Quarter & Fiscal Year 2024 Financial Results From Continuing Operations
Published: February 27, 2025 by: PRNewsWire
Sentiment: Neutral
Making Significant Progress on Stabilizing, Streamlining and Strengthening Organization to Build Long-Term Sustainable, Value Accretive Growth Delivered Fiscal Year 2024 Adjusted EPS of $2.57 the Mid-Point of the Company's Communicated Guidance Range, on Reported Loss of $(1.17) Per Share Fourth Quarter 2024 Infant formula Net Sales Grew 17% Compared to the Prior Year Quarter, Due Primarily to Market Share Gains1 and Recovering Customer Inventory Levels DUBLIN , Feb. 27, 2025 /PRNewswire/ -- Fourth Quarter 2024 Highlights: Net sales of $1.14 billion declined 1.6%, as organic growth of 0.7% was more than offset by unfavorable impacts from divested businesses and exited …
Read More
What's in Store for These 5 Biotech Stocks This Earnings Season?
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Neutral
Let's look at five biotech and drug companies, VTRS, PRGO, NVAX, NTLA and IOVA, slated to release their fourth-quarter 2024 results on Feb. 27, 2025.
Read More
Perrigo Increases Quarterly Dividend by 5%
Published: February 19, 2025 by: PRNewsWire
Sentiment: Neutral
DUBLIN , Feb. 19, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors has approved a 5% increase in the Company's quarterly dividend to $0.290 per share, or $1.16 per share on an annual basis, up from $0.276 per share. This marks the 22nd consecutive year Perrigo has increased its dividend.
Read More
About Perrigo Company plc (PRGO)
- IPO Date 1991-12-17
- Website https://www.perrigo.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Mr. Patrick Lockwood-Taylor
- Employees 8379